No Data
No Data
Express News | NYSE Order Imbalance 159165.0 Shares on Buy Side
Express News | NYSE Order Imbalance 118074.0 Shares on Buy Side
Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens
06:59 AM EDT, 05/28/2024 (MT Newswires) -- Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens
Institutional Owners May Consider Drastic Measures as Bausch Health Companies Inc.'s (NYSE:BHC) Recent US$150m Drop Adds to Long-term Losses
Key Insights Institutions' substantial holdings in Bausch Health Companies implies that they have significant influence over the company's share price The top 11 shareholders own 52% of the company
Bausch Health Announces Wider Public Drug Plan Coverage for Uceris in Canada
Bausch Health's (BHC) Canadian unit said Thursday its Uceris aerosol foam treatment for mild to moderate distal ulcerative colitis in adults has become available for patients in other parts of Canada
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults